curasan develops, manufactures and distributes biomaterials for bone and tissue regeneration. Our proven technologies have set standards of care in dental as well as in orthopedic, trauma and spinal surgery around the globe. But we haven’t finshed yet, and the best is yet to come. Our subsidiary novaxomx researches and develops growth factors based on exosomes – a revolutionary approach to faster and better healing.

We represent a strong portfolio for dental and orthopedic surgery based on clinical evidence and great brands:


Under the CERASORB® umbrella brand, we have established an innovative product line for bone and tissue regeneration. The phase purity of the β-tricalcium phosphate we produce and use in CERASORB® is considered the reference standard* in the market worldwide.
Our products are first choice of orthopedists, trauma and spine surgeons, sports physicians, as well as implantologists, oral and maxillofacial surgeons and specialists in surgical dentistry.

Our innovative products are certified by many international authorities and are available in around 50 countries worldwide.

*International Center of Diffraction Data, USA, ICDD 55-898

This global presence, with a major part of the business in Europe, the USA, China and Japan, is continuously strengthened and expanded by the more than 30 employees at the company headquarters in Frankfurt am Main and our subsidiary curasan, Inc. in Wake Forest, North Carolina USA.

New path.

With the subsidiary novaxomx GmbH, founded in 2022, we are treading a new path in musculoskeletal therapies for bone and tissue regeneration based on exosome technology in combination with biomimetic carrier materials. Exosomes, which contain over 1,000 different growth factors, are considered one of the purest forms and the future of stem cell therapy!